Mirae Asset Global ETFs Holdings’s Amneal Pharmaceuticals AMRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	78,656 +8,136	+12%	+$111K	﹤0.01%	1469
2026 Q1	$877K	Buy	70,520 +629	+0.9%	+$8.45K	﹤0.01%	1577
2025 Q4	$881K	Buy	69,891 +338	+0.5%	+$3.87K	﹤0.01%	1594
2025 Q3	$696K	Sell	69,553 -12,910	-16%	-$116K	﹤0.01%	1696
2025 Q2	$667K	Sell	82,463 -12,175	-13%	-$91.8K	﹤0.01%	1656
2025 Q1	$793K	Buy	94,638 +4,178	+5%	+$34.9K	﹤0.01%	1607
2024 Q4	$716K	Buy	90,460 +2,911	+3%	+$24.4K	﹤0.01%	1725
2024 Q3	$728K	Buy	87,549 +25,723	+42%	+$201K	﹤0.01%	1723
2024 Q2	$393K	Buy	+61,826	New	+$392K	﹤0.01%	1933

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AMRX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Amneal Pharmaceuticals (AMRX) stake by 12% in Q2 2026, buying an estimated $111K and bringing the position to 78,656 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Mirae Asset Global ETFs Holdings first reported a position in AMRX in Q2 2024 and has held it in 9 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 78,656 shares of Amneal Pharmaceuticals worth $1.36M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 8,136 Amneal Pharmaceuticals shares in Q2 2026, an estimated $111K.
Amneal Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1469 holding.
Mirae Asset Global ETFs Holdings first reported a position in Amneal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.